pfizer rsv vaccine news - Search News

Analysis-GSK, Pfizer RSV Vaccine Sales Fall in US

Reuters on MSN · 2h

Analysis-GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and said it was a once-in-a-lifetime shot for now, excluding millions of people who got one last year.

Benzinga.com · 1d

Pfizer Wins London Court Battle, GSK's Respiratory Syncytial Virus Vaccine Patents Invalidated

Pfizer's legal win invalidates two GSK patents in UK RSV vaccine case. On Monday, Pfizer Inc. PFE stock is trading higher with a session volume of 31.16 million as per data from Benzinga Pro. Activist investor Starboard Value has invested approximately $1 ...

The Independent Singapore · 13d

HSA approves Pfizer’s new RSV vaccine

This is the first RSV vaccine approved in Singapore for use in older adults and pregnant individuals, providing critical protection to infants and seniors

Pfizer wins bid to invalidate GSK's patents over RSV vaccine

Pfizer on Monday won a bid in a London court to invalidate two of GSK's patents relating to a respiratory syncytial virus (RSV) vaccine.

Seeking Alpha on MSN · 23h

U.K. court rules in Pfizer's favor in GSK RSV vaccine dispute: report

Pfizer (NYSE:PFE) has reportedly succeeded in getting a U.K. court to invalidate two of GSK’s (NYSE:GSK) patents for its RSV vaccine. The ruling is part of ongoing litigation between the two drugmakers over their respective RSV vaccines.

Pfizer, Starboard

Hosted on MSN · 10h

Why Pfizer Will Find It Hard to Appease Its Activist Investor

The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

Activist investor Starboard Value takes $1 bln stake in Pfizer, sources say

Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer and wants the U.S. drug giant to make changes to turn its performance around, sources familiar with the matter said on Sunday.

EconoTimes · 1d

Activist Investor Starboard Value Takes $1B Stake in Pfizer, Calls for Strategic Overhaul

Activist investor Starboard Value has acquired a $1 billion stake in Pfizer to push for strategic changes in the U.S. pharmaceutical giant. This investment comes as Pfizer contends with declining sales of its

RSV Vaccine Sales Dip as Target Age Group Narrows in U.S.

RSV vaccine sales by GSK and Pfizer have dropped in the U.S. after regulators limited the eligible age group, affecting ...

20h

Low RSV and COVID vaccine usage is in line with investor expectations, but concerning: Jefferies

Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst says, and could mean weak earnings for ...

After a rocky debut for new RSV tools, hopes are high as a new season approaches

Spread of the virus is seasonal, with activity often picking up in the fall after kids go back to school. Activity usually ...

4d

Making an RSV Vaccine Was Hard. Getting People to Take It Is Even Harder

RSV hospitalizes thousands of people in the US every year. Three new vaccines could help stem the spread, but there are ...

The American Journal of Managed Care12d

RSV Vaccines Effective in Older Adults in Long-Term Care Facilities

This study aimed to assess the short-term immune response of an RSV vaccine in a population of older adults 60 years and ...

What to know about the RSV immunization for babies

As many as 80,000 children under 5 are hospitalized each year due to the respiratory syncytial virus, according to the CDC.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results